faculty of dentistry, Fayoum university
Al Fayyum, Egypt
NCT Number: NCT06064786
Aim: The aim of the current study was to compare and correlate gingival crevicular fluid (GCF) fetuin-A levels and high sensitivity C-reactive protein (hs-CRP) levels in non-diabetic periodontitis patients and type 2 diabetic periodontitis patients with healthy subjects and revealing its possible role in diagnosis of periodontal disease.
Methodology: Forty-five periodontitis stage III patients categorized into 3 groups according to whether having type II diabetes mellitus or not were compared to systemically and periodontally healthy participants in this investigation. Clinical parameters for all groups were recorded. Assessment of GCF levels of fetuin A and hs-CRP were done to all enrolled participants utilizing an enzyme linked immune-sorbent assay (ELISA) kit. Receiver operating characteristic (ROC) curve was performed to reveal sensitivity, specificity, predictive value and diagnostic accuracy of the markers used.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Observational
Al Fayyum, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Time frame: levels of fetuin A and hsCRP are measured at baseline after the completion of all GCF sample collection carried at the day of enrollment of subjects in the investigation after diagnosis confirmation
ELIZA kits
Fayoum University
Other
Evaluation of Fetuin-A and hsCRP Levels in Gingival Crevicular Fluid in Periodontitis Diabetic and Non-Diabetic Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07184268
Chronic Disease, Chronic Periodontitis
Cairo, Egypt
View Trial DetailsNCT06426550
Chronic Disease, Chronic Periodontitis
Nova Friburgo, Rio de Janeiro, Brazil
View Trial DetailsNCT07243145
Chronic Disease, Chronic Periodontitis
Niğde, Turkey (Türkiye)
View Trial DetailsNCT07175090
Chronic Disease, Chronic Periodontitis
Pristina, Kosovo
View Trial Details